Jazz Pharmaceuticals
JAZZ
#1980
Rank
HK$81.79 B
Marketcap
HK$1,346
Share price
1.53%
Change (1 day)
26.75%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -HK$5.53 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are HK$4.15 Billion. In 2024 the company made an earning of HK$3.67 Billion, an increase over its 2023 earnings that were of HK$2.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$5.53 Billion-250.23%
2024 HK$3.67 B57.87%
2023 HK$2.32 B-179.92%
2022 -HK$2.92 Billion230.37%
2021 -HK$0.89 Billion-141.02%
2020 HK$2.15 B-39.45%
2019 HK$3.55 B-14.2%
2018 HK$4.13 B20.03%
2017 HK$3.44 B-17.15%
2016 HK$4.16 B22.14%
2015 HK$3.40 B187.64%
2014 HK$1.18 B-50.79%
2013 HK$2.40 B73.63%
2012 HK$1.38 B41.69%
2011 HK$0.97 B116.61%
2010 HK$0.45 B262.77%
2009 HK$0.12 B-111.33%
2008 -HK$1.1 Billion1.31%
2007 -HK$1.09 Billion77.8%
2006 -HK$0.62 Billion36.59%
2005 -HK$0.45 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$127.83 B-2,425.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
HK$16.39 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-HK$18.7 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
HK$16.82 B-406.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel